$5.61
↓ -0.36 (-6.03%)
Trading Downfrom the previous close of
$5.97
YTD change
-53.98%
vs 20-day SMA
-5.16%
vs 200-day SMA
+2.08%
Price ranges
Previous day
$5.69$6.34
open
$5.90close
$5.97
+$0.07 (+1.19%)
Today
$0.00$0.00
$5.61
Past week
$5.10$6.60
from
$5.29now
$5.61
+$0.32 (+6.05%)
Past month
$4.14$7.13
from
$7.11now
$5.61
-$1.50 (-21.10%)
This year
$1.70$13.11
from
$12.19now
$5.61
-$6.58 (-53.98%)
Price & Performance
+0.95 (+18.92%)/ 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
Not So Good
The stock is 77.6% away from all-time highs of $25.00
YDES is down 54% since the beginning of the year
YDES is down 50% over the past 12 months
YDES is down 21% over the past 1 month
7% of all YDES investors are betting against YDES
YDES reads not so good: price sits above one of the two key moving averages, the 12-month move is -47.3%.
Previous minute
+$0.00
Last hour
+$0.00
Last 5 days
+6.05%
vs 8-day SMA
+0.67%
LPRENew premarket low. Next support 5.67 from 10/30/2026.9:28 AM ET
PUDUp 6% for the day.1:22 PM ET
PDDDown 4% for the day.2:54 PM ET
SVCurrently at 1 x average daily volume.2:45 PM ET
VDUTrading 2% above VWAP7:15 PM ET
Financial Strength
Earnings, valuation, and balance sheet
Earnings
ProfitableN/A
EPSN/A
Earnings momentumN/AQuarterly EPS growth
Quarterly changeN/A
Valuation
P/E ratioN/A
Enterprise value$420.2M
Beta-0.52
Balance sheet & scale
IncomeN/A
RevenueN/A
Cash$2.7M
Debt$5.0
Income / DebtN/A
Company & Peers
Company profile and competitor comparison
Company profile
ExchangeNASD
SectorHealth Care and Social Assistance
Sub SectorAmbulatory Health Care Services
Market cap
$397.1M
YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. It operates DNA methylation–based oncology testing programs under an LDT-first strategy and provides compliant life science distribution and clinical trial supply chain services to pharmaceutical and biotechnology partners. The company’s offerings include cancer detection products, regenerative ophthalmology solutions, and exosome-based technologies. YD Bio was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.
Prices and alerts are delayed by at least 20 minutes. Chart history
reflects daily closing prices. Information is provided for research purposes only and is not
investment advice.
Unlock Your Free Account
Sign up free and explore the tools, scans, and dashboards designed to keep you a step ahead.
Explore the tools, scans, and dashboards designed to keep you a step ahead.
